Navigation Links
Galderma, One of the Leading Pharmaceutical Companies, Relies on Verizon Enterprise Solutions to Provide Expanded, Secure Global Communications Platform
Date:3/21/2013

BASKING RIDGE, N.J., March 21, 2013 /PRNewswire/ -- Galderma, a leading global pharmaceutical company focused on dermatology, wanted a cost-efficient means of increasing the capacity of its IT global network infrastructure to support its increasingly data-intensive workload. The company chose a fully managed communications network from Verizon Enterprise Solutions, underpinned by Verizon's comprehensive security solutions and professional service expertise. The result is a secure, reliable global communications platform that Galderma's employees can use to access and share the confidential data, such as medical research and financial data, which drive the company's business growth.

Galderma, headquartered in Switzerland, has 31 wholly owned affiliates with a worldwide network of distributors and more than 4,000 employees. Galderma's extensive product portfolio is available in 70 countries and treats a wide range of dermatological conditions.

As Galderma's business continued to expand, the company sought a global communications provider that could offer greater bandwidth flexibility within a more cost-efficient business model. Verizon's global reach, advanced communications solutions and proven security expertise made the company a logical choice – particularly when supported by the extensive consultancy skills of Verizon's professional services team.

"Highly confidential medical research data has to be handled correctly. Security is our No. 1 concern, and there can be no compromise," said Francois Jolles , director of Global IT infrastructure at Galderma. "Verizon is not only recognized as a global communications expert, but also as a trusted security adviser, and the Verizon team quickly proved they could deliver on our objectives. Verizon's integrated solution has already yielded substantial financial returns:  We have more than doubled our bandwidth capacity for nearly half the cost of what we paid previously. But most importantly, this has been achieved without any compromises on the high service quality and security levels we demand."

The Verizon solution consists of a managed global WAN that spans 42 Galderma sites, including the company's major R&D centers in France, Sweden, Japan and the U.S. as well as manufacturing sites in Brazil, Canada, France and Sweden. Integrated security within the WAN includes Secure Gateway, firewalls and monitoring-management solutions as well as professional services project management.

Verizon Enterprise Solutions creates global connections that generate growth, drive business innovation and move society forward. With industry-specific solutions and a full range of global wholesale products and services offered over the company's secure mobility, cloud, strategic networking and advanced communications platforms, Verizon Enterprise Solutions helps open new opportunities around the world for innovation, investment and business transformation. Visit verizonenterprise.com to learn more.

About Galderma
Galderma is a global company founded in 1981 committed to delivering innovative medical solutions to meet the dermatological needs of people throughout their lifetime while serving healthcare professionals around the world. The company has 31 wholly-owned affiliates with a worldwide network of distributors and more than 4,000 employees. Galderma's extensive product portfolio is available in 70 countries and treats a range of dermatological conditions including: acne, rosacea, onychomycosis, psoriasis & steroid-responsive dermatoses, pigmentary disorders, skin cancer and medical solutions for skin senescence.

With approximately 20% of revenues invested each year to discover and develop new products and access innovative technologies, the company is one of the world's leading investors in dermatology R&D. Four state-of-the-art R&D centers and four manufacturing sites are dedicated to providing a wide range of innovative medical solutions which meet the highest standards of safety and efficacy.

Strategic brands include Epiduo®, Oracea®, Clobex®, Differin®, Rozex®/MetroGel®, Silkis®/Vectical®, Tri-Luma®, Loceryl®, Cetaphil®, Metvix®, Azzalure®, Restylane® and Emervel®.

For more information about Galderma, please visit: www.galderma.com

About Verizon
Verizon Communications Inc. (NYSE, Nasdaq: VZ), headquartered in New York, is a global leader in delivering broadband and other wireless and wireline communications services to consumer, business, government and wholesale customers.  Verizon Wireless operates America's most reliable wireless network, with more than 98 million retail connections nationwide.  Verizon also provides converged communications, information and entertainment services over America's most advanced fiber-optic network, and delivers integrated business solutions to customers in more than 150 countries, including all of the Fortune 500.  A Dow 30 company with nearly $116 billion in 2012 revenues, Verizon employs a diverse workforce of 183,400.  For more information, visit www.verizon.com.


'/>"/>
SOURCE Verizon
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
3. Industry Leading Pharmaceutical News Website in-Pharmatechnologist.com Refocused and Relaunched
4. Remedy Informatics Named "Cool Vendor" in Life Sciences by Leading Technology Analyst Firm
5. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
6. Software Pioneer Leaves $10 Million Bequest To Five Leading Non-profits In Health And Drug Policy Reform
7. Leading Pension Annuity Provider Legal & General, Celebrates 175 Years
8. Denton Vacuum Ships Breakthrough Wafer-level Optics Development System to Leading German R&D Organization
9. FMC Corporation Acquires Phytone, Ltd., a Leading European Natural Colors Business
10. Court Preliminarily Deems Millennium Laboratories Press Release Misleading
11. AstraZeneca and Leading Academic Scientists to Collaborate on Alzheimers Disease Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... April 27, 2016 Shire plc (LSE: ... Poulton , Chief Financial Officer, will present at the Deutsche ... MA on Wednesday, May 04, 2016, 10:00 am ... be available on the Presentations and Webcasts section of Shire,s ... the webcast will be available on this same website for ...
(Date:4/27/2016)... April 27, 2016 Oasmia ... developer of a new generation of drugs within ... survival results for Paclical/Apealea in the Phase III ... with epithelial ovarian cancer. These preliminary results showed ... combination with carboplatin versus Taxol in combination with ...
(Date:4/27/2016)... FRANCISCO , April 27, 2016 ... expected to reach USD 2.06 billion by 2022, ... Research, Inc. Increasing consumer awareness towards a healthy ... the next seven years.      (Logo: ... diet intake coupled with rising health treatment expenditure ...
Breaking Medicine Technology:
(Date:4/28/2016)... ... April 28, 2016 , ... Cosmetic Town, an online plastic surgery community, ... forum section was recently revamped and upgraded to allow even more interaction between doctors ... the country. , According to the senior editor of Cosmetic Town, “We are excited ...
(Date:4/28/2016)... ... April 28, 2016 , ... Horizon ... collaborating with doctors and hospitals to make transformative changes in how health care ... therapy minds this week in discussing breakthroughs in cellular medicine to treat disease. ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... USA Medical Card reminds us that May ... (CDC), a stroke is the fourth leading cause of death in the United States; someone ... almost a quarter of them in individuals under 65 years old. A stroke is ...
(Date:4/28/2016)... PA (PRWEB) , ... April 28, 2016 , ... ... Browne, M.D. has been named a Top Doc in Physical Medicine and Rehabilitation ... conjunction with Castle Connolly Medical, Ltd. by randomly surveying physicians and medical leadership ...
(Date:4/28/2016)... ... April 28, 2016 , ... Denise McCormick Baich had written poetry dating back to her ... again much like a tsunami and took on a more spiritual tone. The desire to ... to do more with it than just file it away. Friends would ask her how ...
Breaking Medicine News(10 mins):